Default company panoramic image

Aprile Pilon's Company

Clarassance is developing novel protein drugs with game-changing potential to modify respiratory diseases, not just treat daily symptoms.

  • Stage Product In Development
  • Industry Biotechnology
  • Location Rockville, MD, USA
  • Currency USD
  • Founded October 2007
  • Employees 7
  • Website

Company Summary

Clarassance is a clinical stage biotechnology company with lead product ready to enter Phase2 clinical trials for persistent sinusitis and in premature babies. There is an unmet need for new drugs to treat respiratory diseases that will be addressed by the company's products. The plan is to complete at least one Ph2 trial and then secure a large pharmaceutical partner. The desired exit is a sale of the company in 3-5 years.


  • Default avatar
    Aprile L. Pilon, Ph.D.
    President & CEO

    Dr. Aprile Pilon is the Founder & CEO. She is a serial entrepreneur and Clarassance is her fourth start-up venture and second venture-backed biotechnology business. Dr. Pilon has over 18 years of entrepreneurial experience in the biopharmaceutical industry, including project management, fundraising, team building, corporate governance, licensing and IP strategy, regulatory strategy, and business development.

  • Default avatar
    Phillippe Rousseau
    Acting CFO

    Mr. Rousseau is a serial biotech entrepreneur with 18 years of experience in biotech/pharma corporate finance, fundraising, investor relations, and M&A.

  • Default avatar
    Lisa Beth Ferstenberg, M.D.
    Acting Chief Medical Officer

    Dr. Ferstenberg has over 27 years of experience directing clinical product development, as well as executive experience in pharmaceutical and biotechnology companies.

  • Default avatar
    Suzanne M Sensabaugh
    Acting Director, Regulatory Affairs

    Ms. Sensabaugh has over 20 years of experience in regulatory affairs, including 10 years at FDA and 12 years in industry.

  • Default avatar
    Matthias Alder
    Acting VP, Business Development

    Mr. Alder is an attorney with 18 years of experience in biotech/pharma business law, license & M&A negotiations and transactions.


  • Default avatar
    Gregory S. Feis, Esq.
    Default avatar
    Gelman, Rosenberg, & Freedman

Previous Investors

  • Default avatar
    Zell Biotech LLC